Spartan Capital Securities Serves as Sole Placement Agent in Virpax Pharmaceuticals’ $6 Million Follow-On Offering
January 30 2025 - 2:59PM
Spartan Capital Securities, LLC, a leading full-service investment
banking and financial advisory firm, is proud to announce its role
as sole placement agent for Virpax Pharmaceuticals, Inc. (Nasdaq:
VRPX) in the successful close of its $6 million follow-on offering.
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) is a
preclinical-stage pharmaceutical company pioneering novel drug
delivery systems for pain management and central nervous system
disorders. The proceeds from the offering will enable Virpax to
support the ongoing clinical trial development of Probudur, fund
marketing and advertising efforts, for general corporate purposes,
and to provide working capital.
"We are pleased to support Virpax Pharmaceuticals in this
offering and look forward to seeing the continued progress of their
innovative drug delivery technologies," said John Lowry, CEO of
Spartan Capital Securities. "Spartan Capital remains committed to
helping emerging biotech and pharmaceutical companies access the
capital they need to advance groundbreaking solutions that address
unmet medical needs."
Legal counsel for Virpax Pharmaceuticals was provided by
Sichenzia Ross Ference Carmel LLP, with representation by Ross
Carmel and Benjamin Sklar. Spartan Capital Securities was
represented by Lucosky Brookman LLP, with Scott Linsky, Raymond
Ressy, and Xiafan Cheng serving as counsel.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction where such offer,
solicitation, or sale would be unlawful prior to registration or
qualification under applicable securities laws.
About Virpax Pharmaceuticals, Inc.
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) is a
preclinical-stage pharmaceutical company focused on developing
novel and proprietary drug delivery systems to address various pain
indications and enhance compliance. The company’s innovative
pipeline aims to advance non-opioid and non-addictive treatments
for pain and central nervous system disorders, improving the
quality of life for patients worldwide.
About Spartan Capital Securities, LLC
Spartan Capital Securities, LLC is a premier full-service
investment banking firm offering a comprehensive range of advisory
services to institutional clients and high-net-worth individuals.
Known for its expertise in capital raising, strategic advisory, and
asset management, Spartan Capital delivers tailored solutions to
meet clients' financial goals. For more information about Spartan
Capital Securities, visit www.spartancapital.com.
Contact: Spartan Capital Securities, LLC 45 Broadway, 19th Floor
New York, NY 10006 investmentbanking@spartancapital.com
Virpax Pharmaceuticals (NASDAQ:VRPX)
Historical Stock Chart
From Dec 2024 to Jan 2025
Virpax Pharmaceuticals (NASDAQ:VRPX)
Historical Stock Chart
From Jan 2024 to Jan 2025